About
ChromaGenix develops peptide ligand-based affinity chromatography products and purification technologies for downstream bioprocessing of complex biologics including antibodies, viral vectors (AAV, lentivirus), and mRNA therapeutics.
Explore ChromaGenix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.